Justine Telliez
Stock Analyst at Kepler Capital
(4.93)
# 188
Out of 5,058 analysts
354
Total ratings
53.7%
Success rate
60.1%
Average return
Main Sectors:
Stocks Rated by Justine Telliez
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: DBV DBV Technologies S.A. | Reiterated: Buy | €5.50 | €1.62 | +238.88% | 26 | May 4, 2026 | |
| EPA: GBT Guerbet SA | Reiterated: Hold | €13.80 | €6.25 | +120.80% | 24 | Apr 24, 2026 | |
| BIT: PHIL Philogen S.p.A. | Reiterated: Buy | €34.00 | €21.25 | +60.00% | 1 | Apr 24, 2026 | |
| SWX: GALD Galderma Group AG | Reiterated: Buy | CHF 167.00 | CHF 172.15 | -2.99% | 12 | Apr 23, 2026 | |
| EPA: ADOC Adocia SA | Reiterated: Buy | €12.00 | €2.57 | +366.93% | 26 | Apr 22, 2026 | |
| EPA: IPN Ipsen S.A. | Reiterated: Hold | €132.00 | €148.50 | -11.11% | 35 | Apr 22, 2026 | |
| EPA: ABVX ABIVAX Société Anonyme | Reiterated: Buy | €130.00 | €81.95 | +58.63% | 33 | Apr 13, 2026 | |
| EPA: SIGHT GenSight Biologics S.A. | Reiterated: Hold | €0.40 | €0.08 | +426.32% | 31 | Apr 8, 2026 | |
| EPA: GNFT Genfit S.A. | Reiterated: Buy | €15.00 | €8.14 | +84.28% | 42 | Apr 7, 2026 | |
| SWX: IDIA Idorsia Ltd | Reiterated: Buy | CHF 4.50 | CHF 4.20 | +7.19% | 36 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €7.70 → €5.60 | €2.59 | +116.63% | 63 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €3.10 | €1.29 | n/a | 24 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.30 | €0.97 | n/a | 1 | Dec 1, 2023 |
DBV Technologies S.A.
May 4, 2026
Reiterated: Buy
Price Target: €5.50
Current: €1.62
Upside: +238.88%
Guerbet SA
Apr 24, 2026
Reiterated: Hold
Price Target: €13.80
Current: €6.25
Upside: +120.80%
Philogen S.p.A.
Apr 24, 2026
Reiterated: Buy
Price Target: €34.00
Current: €21.25
Upside: +60.00%
Galderma Group AG
Apr 23, 2026
Reiterated: Buy
Price Target: CHF 167.00
Current: CHF 172.15
Upside: -2.99%
Adocia SA
Apr 22, 2026
Reiterated: Buy
Price Target: €12.00
Current: €2.57
Upside: +366.93%
Ipsen S.A.
Apr 22, 2026
Reiterated: Hold
Price Target: €132.00
Current: €148.50
Upside: -11.11%
ABIVAX Société Anonyme
Apr 13, 2026
Reiterated: Buy
Price Target: €130.00
Current: €81.95
Upside: +58.63%
GenSight Biologics S.A.
Apr 8, 2026
Reiterated: Hold
Price Target: €0.40
Current: €0.08
Upside: +426.32%
Genfit S.A.
Apr 7, 2026
Reiterated: Buy
Price Target: €15.00
Current: €8.14
Upside: +84.28%
Idorsia Ltd
Mar 30, 2026
Reiterated: Buy
Price Target: CHF 4.50
Current: CHF 4.20
Upside: +7.19%
Mar 26, 2026
Reiterated: Buy
Price Target: €7.70 → €5.60
Current: €2.59
Upside: +116.63%
May 23, 2025
Reiterated: Hold
Price Target: €3.10
Current: €1.29
Upside: n/a
Dec 1, 2023
Reiterated: Buy
Price Target: €16.30
Current: €0.97
Upside: n/a